Higher expression of FGF19 in HCCs promotes tumor cell survival and has antiapoptotic effects that are exerted through the FGFR4-glycogen synthase kinase (GSK)3β-Nrf2 signaling cascade [33]. The gene discussed is GSK3B; the disease is neoplasm.